» Articles » PMID: 17804704

Overexpression of the MicroRNA Hsa-miR-200c Leads to Reduced Expression of Transcription Factor 8 and Increased Expression of E-cadherin

Overview
Journal Cancer Res
Specialty Oncology
Date 2007 Sep 7
PMID 17804704
Citations 214
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs are approximately 22-nucleotide sequences thought to interact with multiple mRNAs resulting in either translational repression or degradation. We previously reported that several microRNAs had variable expression in mammalian cell lines, and we examined one, miR-200c, in more detail. A combination of bioinformatics and quantitative reverse transcription-PCR was used to identify potential targets and revealed that the zinc finger transcription factor transcription factor 8 (TCF8; also termed ZEB1, deltaEF1, Nil-2-alpha) had inversely proportional expression levels to miR-200c. Knockout experiments using anti-microRNA oligonucleotides increased TCF8 levels but with nonspecific effects. Therefore, to investigate target predictions, we overexpressed miR-200c in select cells lines. Ordinarily, the expression level of miR-200c in non-small-cell lung cancer A549 cells is low in contrast to normal human bronchial epithelial cells. Stable overexpression of miR-200c in A549 cells results in a loss of TCF8, an increase in expression of its regulatory target, E-cadherin, and altered cell morphology. In MCF7 (estrogen receptor-positive breast cancer) cells, there is endogenous expression of miR-200c and E-cadherin but TCF8 is absent. Conversely, MDA-MB-231 (estrogen receptor-negative) cells lack detectable miR-200c and E-cadherin (the latter reportedly due to promoter region methylation) but express TCF8. The ectopic expression of miR-200c in this cell line also reduced levels of TCF8, restored E-cadherin expression, and altered cell morphology. Because the down-regulation of E-cadherin is a crucial event in epithelial-to-mesenchymal transition, loss of miR-200c expression could play a significant role in the initiation of an invasive phenotype, and, equally, miR-200c overexpression holds potential for its reversal.

Citing Articles

Research trend of lung cancer epigenetics research: Bibliometric and visual analysis of top-100 cited documents.

Lou W, Li Y Heliyon. 2024; 10(15):e35686.

PMID: 39170116 PMC: 11337132. DOI: 10.1016/j.heliyon.2024.e35686.


Initial development and testing of an exhaled microRNA detection strategy for lung cancer case-control discrimination.

Shi M, Han W, Loudig O, Shah C, Dobkin J, Keller S Sci Rep. 2023; 13(1):6620.

PMID: 37095155 PMC: 10126132. DOI: 10.1038/s41598-023-33698-8.


The study of miRNA-200c expression and epithelial-to-mesenchymal transition-related transcription factors in the primary bladder urothelial carcinoma.

Narwal A, Kumari K, Kaushal S, Seth A, Nayak B, Rustagi Y Urol Ann. 2023; 15(1):35-42.

PMID: 37006208 PMC: 10062515. DOI: 10.4103/ua.ua_72_22.


MicroRNA in lung cancer-a novel potential way for early diagnosis and therapy.

Frydrychowicz M, Kuszel L, Dworacki G, Budna-Tukan J J Appl Genet. 2023; 64(3):459-477.

PMID: 36821071 PMC: 10457410. DOI: 10.1007/s13353-023-00750-2.


High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer.

Oshi M, Tokumaru Y, Benesch M, Sugito N, Wu R, Yan L Am J Cancer Res. 2022; 12(10):4840-4852.

PMID: 36381329 PMC: 9641402.